Free Republic

Thomas Lifson's 10/26/2020 informative post detailed how Europe is now experiencing a second wave of COVID deaths.  The American mainstream media echoed the claim about the COVID spike in Europe and are also claiming that a similar one is happening in the USA based mostly on increased positive tests.  However, that trend correlates closely with the increased testing.  Unbiased COVID-19 data for this analysis was found in an interactive chart from Our World in Data.  Their COVID-19 data uses a seven-day moving average of daily deaths per million people to make it easier to compare trends for large and small countries.  I selected...

by CrownHeights.infoIt took months of denials, an endorsement from President Trump, and many misrepresented studies, but a case study of Dr. Zelenko’s protocol has finally been published, and it shows he was right.Published on ScienceDirect.com, the peer-reviewed study was the first to look at early, out of hospital treatment of COVID-19 with Zelenko’s protocol of Hydoxychloraquin, Zinc, and Azithromycin.While other studies looked at the effects of Hydroxychloriquin alone, or treatment during the later stages of the COCID-19 infection, this is the first to look at Zelenko’s entire Protocol, including dosages and timetables.The case study of 141 patients treated within...

Dr. Brian Tyson’s First-Person Account of COVID-19 This is a first-person account by Dr Brian Tyson about his unique experience with COVID-19. You are most welcome also to watch our extensive interview with Dr Brian Tyson, if you haven’t do so yet. We heard about a virus coming out of Wuhan, China, in January of 2020.  I had a feeling it was going to makes its way to the US due to all the international travel.  I told my wife Fabiola; we need to get prepared, and we are going to need a plan.  It was long before we started...

     Truth stands the test of time.  We are currently engaged in World War III with over 210 countries fighting the same invisible enemy.[1] Regardless of the root causes of the Covid-19 pandemic, the world’s response to this crisis is killing more people than the actual virus.  In this response, I see  powerful and methodical groups colluding to obstruct the flow of life-saving information and medication.  Let me explain.      In early March, I was forced by circumstance to treat my patients with Covid-19 in the out-patient setting.  With divine providence, research and a battlefield medicine approach of...

The French official agency for medications, that depends directly on France’s Health Minister Véran, has refused to temporary use approval for hydroxychloroquine to the Marseille University Hospital, headed by Professor Didier Raoult. According to the October 23 communiqué, “To date, the available data, which are very heterogeneous and uneven, do not allow us to predict a benefit from hydroxychloroquine, alone or in combination, for the treatment or prevention of Covid-19 disease. In this context and in view of the available safety data showing increased risks, in particular cardiovascular risks, it cannot be assumed that hydroxychloroquine has a favorable risk...

Narcissist Dr. Anthony Fauci is terrorizing the public again with endless media appearances.  Rather than talk about medicines that can cure the coronavirus, like those given to President Trump, he is peddling fear by talking about 300,000 to 400,000 deaths.  He pushes his favorite solutions, namely masks and lockdowns.  Leftist media can’t get enough Fauci.  [Interestingly, he is the highest-paid federal employee with a salary of $417,608 versus $400,000 for the president.] There is some mystery about why hospitalized President Trump was infused with the dubious, ultra-expensive medicine remdesivir and an experimental antibodies medicine.  Why not use hydroxychloroquine?  He previously took...

An international group of researchers believe there is enough evidence that anti-malarial drugs could be repurposed to treat COVID-19 and that they should be assessed for efficacy in clinical trials. The review article, published online in Trends in Parasitology, outlines the evidence for the antiviral and anti-inflammatory properties of certain anti-malarial drugs that could play a role in tackling COVID-19. The research group, from institutions across Europe, Asia and Africa, point to a combination of the drugs artesunate and pyronaridine as the most promising. Both drugs have demonstrated antiviral effects on the SARS-CoV-2 virus in human lung cells in laboratory...

Even as the search for the coronavirus vaccine continues, there is a lot of confusion and contradictory views regarding usage of drugs to fight against COVID-19. Some health officials, including specialists from Melbourne, recently suggested to the doctors in India to prescribe Ivermectin, a drug used to treat lice and other parasites, to treat coronavirus. Dr Shashikant Manikappa, specialist cardiac anesthetist of Monash Health, Melbourne (Australia), said that medications like Hydroxychloroquine, and more recently Ivermectin, had shown some promising results against coronavirus. But despite some promising results, the Indian Council of Medical Research (ICMR) hasn't included Ivermectin in its treatment...

Hydroxychloroquine is ineffective and unsafe in the treatment of COVID-19: This is the belief held by millions of Americans and many healthcare professionals. After months of randomized clinical trials yielding findings that were not statistically significant, and others reporting side effects, no one could be blamed for reaching this conclusion. But an important slice of the hydroxychloroquine data tells a different story. Because of the medication’s politicization, and the pernicious tendency for dissenting perspectives to be silenced during the pandemic, data supporting hydroxychloroquine’s effectiveness have been almost inaudible. But a recent analysis pooling together results of randomized clinical trials testing...

Rudy Giuliani, personal attorney for President Donald Trump, told Bloomberg TV he is taking hydroxychloroquine even after twice testing negative for coronavirus. During a Monday interview on Fox News, Giuliani coughed, prompting some to wonder about his coronavirus status. He tweeted that a coronavirus test he took prior to the interview came back negative. “Well, again I’m lucky because I just got back a NEGATIVE result for COVID-19. My prayers go out to my colleagues for a swift and complete recovery!” Giuliani tweeted on Monday. Giuliani said his doctor, who he called a “genius,” prescribed hydroxychloroquine as a preventive precaution....

President Donald Trump has been touting chloroquine and hydroxychloroquine since March as effective treatments for COVID-19. He even took hydroxychloroquine as a prophylactic measure for two weeks in May. Last week, when the president was hospitalized for a COVID-19 infection, his physicians listed the medications with which he is being treated. Hydroxychloroquine is notable by its absence. Instead, the president has been aggressively treated with Regeneron Pharmaceuticals' polyclonal antibodies. This combination of two monoclonal antibodies aims to block the coronarvirus from infecting cells, providing extra time for patients' immune systems to ramp up their own natural defenses against the virus....

Highlights • Hydroxychloroquine (HCQ) 2400 mg over 5 days was used in Belgium for COVID-19.• Impact of HCQ on mortality among 8075 patients with COVID-19 was assessed.• Lower mortality in HCQ-treated patients as compared to supportive care.• Lower mortality was irrespective of symptom duration. ABSTRACT Hydroxychloroquine (HCQ) has been largely used and investigated as therapy for COVID-19 across various settings at a total dose usually ranging from 2400 mg to 9600 mg. In Belgium, off-label use of low-dose HCQ (total 2400 mg over 5 days) was recommended for hospitalised patients with COVID-19. We conducted a retrospective analysis of in-hospital mortality...

Abstract Background Hydroxychloroquine (HCQ) was proposed as potential treatment for COVID-19. Objective We set-up a multicenter Italian collaboration to investigate the relationship between HCQ therapy and COVID-19 in-hospital mortality. Methods In a retrospective observational study, 3,451 unselected patients hospitalized in 33 clinical centers in Italy, from February 19, 2020 to May 23, 2020, with laboratory-confirmed SARS-CoV-2 infection, were analyzed. The primary end-point in a time-to event analysis was in-hospital death, comparing patients who received HCQ with patients who did not. We used multivariable Cox proportional-hazards regression models with inverse probability for treatment weighting by propensity scores, with the addition...

There have now been 126 international studies on HCQ (hydroxychloroquine) and its effectiveness in treating the coronavirus. 76 of these international studies are peer reviewed. 64%, or nearly 2/3’s of the studies found HCQ effective in treating COVID-19 in the early treatment stage of the disease.After President Trump announced he had been tested positive for the coronavirus Dr. David Samadi, a top 100 US doctor tweeted out encouragement to President Trump and suggested the proven early treatment of HCQ, zinc and Zpack. For this Dr. Zamadi was banned from Twitter. It is almost like the leftists at Twitter want...

VIDEO Last May, the DUmmie FUnnies was the FIRST to break the story about Amy Klobuchar admitting that her husband was treated with hydroxychloroquine for his severe case of Coronavirus. Since he walked out of the hospital several days later perfectly healthy, should President Trump use the same treatment that seemed to have worked so well for Klobuchar's husband?

The Spanish have reported an improvement to the HCQ treatment. Their "standard of care" includes HCQ. In a new study, 76 patients with Covid-19 were treated: 26 with "standard of care" and 50 with "standard of care" + a high dose Vitamin D analog (calcifediol ). For the group receiving calcifediol, only 1 (of 50) had to go to the ICU, and none died. For the group not receiving calcifediol, 13 (of 26) went to the ICU and 2 died.

Australian scientists have vowed to continue investigating whether taking hydroxychloroquine can stop people becoming infected with coronavirus. Researchers from the Walter & Eliza Hall Institute in Melbourne believe the drug could prevent people catching SARS-CoV-2 - the virus that causes COVID-19. Hundreds of health workers in NSW and Victoria have been given the drug in the Institute's COVID SHIELD trial in an effort to try and determine its effectiveness as a prophylactic. Hydroxychloroquine was brought to public attention when US President Donald Trump said he was using the malaria drug to 'protect' himself from coronavirus. Prescriptions for the drug subsequently...

In a clinical trial testing whether a daily regimen of hydroxychloroquine could protect those most likely to be exposed to COVID-19, researchers from the Perelman School of Medicine at the University of Pennsylvania found there was no difference in infection rates among health care workers who took the drug versus those taking a placebo. While the researchers observed a lack of effect associated with hydroxychloroquine, infection levels were low among the participants, which the researchers believe points to the effectiveness of other prevention measures in the health system: social distancing, use of personal protective equipment, and proper hand hygiene. The...

TEGUCIGALPA, Honduras, Sept. 28, 2020 -- CATRACHO, the COVID-19 treatment method Honduras is using to save lives, was one of the 150 formulas chosen from 30,000 ones presented at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Conference on Coronavirus, with the co-participation of the American Infectious Diseases Association, in Basel, Switzerland. The research presented by Honduran doctors Óscar Díaz, Fernando Valerio and Miguel Sierra, creators of Catracho treatment, will be published as one of the great contributions in reducing deaths by Covid-19. Catracho – as Hondurans are colloquially called – is an acrostic made up of the...

Main Article Content Rafat Zreiq Department of Public Health, College of Public Health and Health Informatics, University of Ha'il, Ha'il, Saudi Arabia. and Molecular Diagnostic and Personalised Therapeutics Unit, University of Ha'il, Ha'il, Kingdom of Saudi Arabia. Najoua Haouas Laboratory of Medical and Molecular Parasitology-Mycology LP3M (Code LR12ES08), Department of Clinical Biology, Faculty of Pharmacy, University of Monastir, Tunisia. Asma M. Khemakhem Department of Biology, Faculty of Science of Sfax, University of Sfax, Sfax, Tunisia. Rawan M. Obeidat Department of Public Health, College of Public Health and Health Informatics, University of Ha'il, Ha'il, Saudi Arabia. Reem M. Ali Department of...